Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
897 studies found for:    Uterine Cancer: Clinical Trials
Show Display Options
RSS Create an RSS feed from your search for:
Uterine Cancer: Clinical Trials
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed A Phase II Trial of Adjuvant Radiation Therapy With Ifosfamide in Patients With MMT of the Uterus
Condition: Uterine Cancer
Interventions: Drug: Ifosfamide;   Procedure: Radiation Therapy
2 Recruiting Clinical Trial of Intraperitoneal Hyperthermic Chemotherapy
Conditions: Ovarian Cancer;   Peritoneal Cancer;   Fallopian Tube Cancer;   Uterine Cancer;   Mesotheliomas;   Gastrointestinal Cancers;   Cervical Cancer
Interventions: Device: HIPEC: MMC 30mg @ T0, 10mg @ T45min;   Device: HIPEC: MMC + CDDP 30mg @ T0, 10mg @ T45min 50 mg/m2 @T0;   Device: HIPEC: CDDP 75 mg/m2 @T0;   Device: HIPEC: CDDP+ Doxorubicin 50 mg/m2 @T0 15 mg/m2 @T0
3 Completed Uterine Papillary Serous Cancer (UPSC) Trial
Condition: Uterine Cancer
Intervention: Drug: Paclitaxel, Carboplatin
4 Terminated Feasibility Trial of Intraperitoneal Chemotherapy for Ovarian, Fallopian Tube, and Primary Peritoneal Carcinoma
Conditions: Ovarian Cancer;   Fallopian Tube Cancer;   Primary Peritoneal Carcinoma;   Uterine Cancer
Intervention: Drug: Paclitaxel, Cisplatin IP
5 Active, not recruiting Diet and Physical Activity in Uterine Cancer Survivors
Condition: Endometrial Neoplasms
Intervention: Behavioral: Shape-Up following cancer treatment
6 Active, not recruiting Patient, Physician, and Nurse Factors Associated With Entry Onto Clinical Trials and Finishing Treatment in Patients With Primary or Recurrent Uterine, Endometrial, or Cervical Cancer
Conditions: Recurrent Cervical Carcinoma;   Recurrent Uterine Corpus Carcinoma;   Recurrent Uterine Corpus Sarcoma;   Stage I Uterine Corpus Cancer;   Stage I Uterine Sarcoma;   Stage IA Cervical Cancer;   Stage IB Cervical Cancer;   Stage II Uterine Corpus Cancer;   Stage II Uterine Sarcoma;   Stage IIA Cervical Cancer;   Stage IIB Cervical Cancer;   Stage III Cervical Cancer;   Stage III Uterine Corpus Cancer;   Stage III Uterine Sarcoma;   Stage IV Uterine Corpus Cancer;   Stage IV Uterine Sarcoma;   Stage IVA Cervical Cancer;   Stage IVB Cervical Cancer
Interventions: Other: Medical Chart Review;   Other: Questionnaire Administration
7 Not yet recruiting Developing a Stepped Approach to Improving Sexual Function aFteR Treatment fOr gyNaecological Cancer
Conditions: Cervical Cancer;   Ovarian Cancer;   Uterine Cancer;   Vaginal Cancer;   Vulval Cancer;   Psychosexual Dysfunctions
Intervention: Behavioral: SAFFRON stepped care
8 Active, not recruiting Pillars4Life Trial
Conditions: Breast Cancer;   Lung Cancer;   Esophageal Cancer;   Colon Cancer;   Pancreatic Cancer;   Liver Cancer;   Renal Cancer;   Bladder Cancer;   Prostate Cancer;   Ovarian Cancer;   Cervical Cancer;   Uterine Cancer
Intervention: Behavioral: Pillars4Life
9 Recruiting A Randomized Controlled Trial of an Online Support Group for Sexual Distress Due to Gynecologic Cancer
Conditions: Sexual Dysfunctions, Psychological;   Uterine Cervical Neoplasms;   Ovarian Neoplasms;   Uterine Neoplasms;   Genital Neoplasms, Female
Intervention: Behavioral: GyneGals Support Group
10 Completed The RECHARGE Low Carbohydrate Diet Trial for Metastatic Cancer
Conditions: Cancer;   Breast Cancer;   Colon Cancer;   Cervical Cancer;   Uterine Cancer;   Ovarian Cancer
Intervention: Behavioral: Very low carbohydrate diet (approximately 20 grams per day)
11 Recruiting Clinical Trial to Evaluate the Safety and Effectiveness of GDC-0032 When Given Alongside Tamoxifen
Conditions: Breast Cancer;   Ovarian Cancer;   Cancer of the Uterus
Interventions: Drug: GDC-0032;   Drug: Tamoxifen
12 Completed Laparoscopic Surgery or Standard Surgery in Treating Patients With Endometrial Cancer or Cancer of the Uterus
Conditions: Endometrial Adenocarcinoma;   Stage I Uterine Corpus Cancer;   Stage I Uterine Sarcoma;   Stage II Uterine Corpus Cancer;   Stage II Uterine Sarcoma
Interventions: Procedure: Laparoscopic Surgery;   Other: Quality-of-Life Assessment;   Procedure: Therapeutic Conventional Surgery
13 Recruiting Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With Uterine Cancer
Conditions: Stage IA Uterine Sarcoma;   Stage IB Uterine Sarcoma;   Stage IC Uterine Sarcoma;   Stage IIA Uterine Sarcoma;   Stage IIB Uterine Sarcoma;   Stage IIIA Uterine Sarcoma;   Stage IIIB Uterine Sarcoma;   Stage IIIC Uterine Sarcoma;   Stage IVA Uterine Sarcoma;   Stage IVB Uterine Sarcoma;   Uterine Carcinosarcoma
Interventions: Drug: paclitaxel;   Drug: carboplatin;   Radiation: external beam radiation therapy;   Radiation: brachytherapy;   Radiation: intensity-modulated radiation therapy;   Other: laboratory biomarker analysis
14 Active, not recruiting Olaparib in Combination With Carboplatin for Refractory or Recurrent Women s Cancers
Conditions: Cervical Cancer;   Ovarian Cancer;   Breast Cancer;   Primary Peritoneal Cancer;   Fallopian Tube Cancer;   Endometrial Cancer
Interventions: Drug: Carboplatin;   Drug: Olaparib
15 Completed Combination Chemotherapy Consisting of Pegylated Liposomal Doxorubicin and Carboplatin in Malignant Gynecologic Tumours
Conditions: Cancer of the Ovary Treated as 2nd Line Therapy;   Muellerian Mixed Tumours;   Tumours of the Uterus;   Cervical Cancers;   Non-Epithelial Ovarian Tumours
Intervention: Drug: Pegylated Liposomal Doxorubicin and Carboplatin
16 Completed Emmy Trial: Uterine Artery Embolization (UAE) Versus Hysterectomy for Uterine Fibroids
Conditions: Menorrhagia;   Leiomyoma;   Uterine Neoplasms
Interventions: Procedure: uterine artery embolization;   Procedure: hysterectomy
17 Completed Efficacy Study of Weekly Taxotere and Topotecan for Recurrent Gynecologic (GYN) Cancers
Conditions: Ovarian Neoplasms;   Uterine Neoplasms
Intervention: Drug: Topotecan and Taxotere
18 Recruiting Paclitaxel and Intraperitoneal Carboplatin Followed by Radiation Therapy in Treating Patients With Stage IIIC-IV Uterine Cancer
Conditions: Endometrial Serous Adenocarcinoma;   Stage IIIA Uterine Corpus Cancer;   Stage IIIB Uterine Corpus Cancer;   Stage IIIC1 Uterine Corpus Cancer;   Stage IIIC2 Uterine Corpus Cancer;   Stage IVA Uterine Corpus Cancer;   Stage IVB Uterine Corpus Cancer
Interventions: Drug: Paclitaxel;   Drug: Carboplatin;   Radiation: 3-Dimensional Conformal Radiation Therapy;   Radiation: Intensity-Modulated Radiation Therapy;   Other: Quality-of-Life Assessment;   Other: Laboratory Biomarker Analysis
19 Completed A Trial for Patients With Gestational Trophoblastic Disease
Conditions: Trophoblastic Neoplasms;   Uterine Neoplasms;   Hydatidiform Mole;   Choriocarcinoma
Intervention: Drug: Pemetrexed
20 Terminated A Pilot Study of Celecoxib in Patients With Grade 2 or 3 Uterine Cancers
Condition: Uterine Cancer
Intervention: Drug: Celecoxib

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years